Arizona legislation · Fifty-seventh Legislature - Second Regular Session (2026)
Arizona SB1214: stem cells; birth tissue; therapy
Status: Vetoed, June 19, 2026
SB1214 - (NOW: stem cells; regenerative therapy)
What the bill says
An act Amending title 32, chapter 32, Arizona Revised Statutes, by adding article 2.1; relating to the practice of medicine.
From the engrossed text, April 14, 2026:
AN ACT Amending title 32, chapter 32, Arizona Revised Statutes, by adding article 2.1; relating to the practice of medicine. (TEXT OF BILL BEGINS ON NEXT PAGE) Be it enacted by the Legislature of the State of Arizona: Section 1. Title 32, chapter 32, Arizona Revised Statutes, is amended by adding article 2.1, to read: ARTICLE 2.1. STEM CELL AND regenerative THERAPY START_STATUTE32-3235. Definitions In this article, unless the context otherwise requires: 1. "Provider" means any health professional who is licensed pursuant to this title and whose scope of practice includes stem cell or regenerative therapy. 2. "Stem cell or regenerative therapy" means a treatment that involves the use of CELLS, TISSUES OR BIOLOGIC MATERIALS THAT ARE DERIVED EXCLUSIVELY FROM ADULT DONORS OR FROM afterbirth, including placental CELLS, perinatal cells, amniotic fluid OR UMBILICAL CORD BLOOD, that may be autologous or allogeneic or culture expanded and that complies with the requirements prescribed in this article. END_STATUTE START_STATUTE32-3236. Stem cell therapy; regenerative therapy; ethical requirements; informed consent; records; advertising; unprofessional conduct; civil action A. A provider may perform stem cell or regenerative therapy that is not approved by the United States food and drug administration if all of the following apply: 1. The stem cell or regenerative therapy is within the provider's lawful scope of practice. 2. The provider has completed …
Sponsors
- Janae Shamp (R, SD-029) · primary sponsor
Latest actions
- : Governor Vetoed
- : Transmitted to Governor
- : Passed
- : failed to pass
- : Passed
- : Passed
- : do pass amended
- : Passed
- : Passed
- : failed to pass
Votes
- FINAL Passed (June 12, 2026): 16 yea, 13 nay, passed
- FINAL failed to pass (June 11, 2026): 15 yea, 12 nay, failed
- THIRD Passed (June 9, 2026): 38 yea, 18 nay, passed
- THIRD failed to pass (April 21, 2026): 25 yea, 31 nay, failed
- RULES C&P (March 30, 2026): 8 yea, 0 nay, passed
- HHS DPA (March 23, 2026): 9 yea, 3 nay, passed
Common questions
- What is SB1214?
- SB1214 is a bill in the Arizona Legislature (Fifty-seventh Legislature - Second Regular Session (2026)): stem cells; birth tissue; therapy.
- What does SB1214 do?
- In its own words: An act Amending title 32, chapter 32, Arizona Revised Statutes, by adding article 2.1; relating to the practice of medicine.
- What is the status of SB1214?
- Vetoed as of June 19, 2026. Latest action: Governor Vetoed (June 19, 2026).
- Who sponsored SB1214?
- Janae Shamp (R, SD-029).
- Where is the official record for SB1214?
- On the Arizona Legislature website: https://apps.azleg.gov/BillStatus/BillOverview/84352/?SessionId=130
Source: official Arizona record. Tracked by Delilah, AI for legislation across all 50 states and Congress.